Preventing HIV with a Pill
A single pill could soon become an important tool in the fight against HIV.
Some Patients Might Not Know They Have HIV
Patients with HIV are now able to live longer and healthier lives than ever before — but only when their HIV status is known and treated.
Why Early HIV Treatment Matters
There may be some good news for HIV patients — starting medication immediately after diagnosis may help keep patients healthy longer.
Anti-Herpes Rx Did Double Duty
Genital herpes and HIV are similar in that both are sexually transmitted viruses — and now it looks as though they might also respond to the same medication.
HIV May Hamper Hearing
Hearing loss may not always be the result of too much loud music in your younger days. If you're HIV-positive, hearing loss could be a product of your condition.
Early Therapy May Keep HIV Patients Healthy
They say timing is everything — and that may apply to HIV treatment. Starting antiretroviral therapy early may keep HIV patients healthy.
On World AIDS Day, Organizers Focus on Raising Awareness
Today is World AIDS Day, a special day to raise awareness about HIV and AIDS and to bring people together in the fight against the epidemic. This year's theme is "Focus, Partner, Achieve: An AIDS-Free Generation."
HIV Patients Not Receiving Regular Care
With new medications and treatments, HIV therapy has dramatically improved over the past two decades. Many with the virus, however, may not be getting proper treatment.
FDA Approves New Rx for Combination with Other HIV Medications
On September 24, 2014, FDA approved Vitekta (elvitegravir) 85 mg and 150 mg tablets.
FDA Approves New Rx for Combination with HIV Medications
On September 24, 2014, FDA approved Tybost (cobicistat) 150 mg tablets. Tybost is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection.